With regard to the Interim Federal Health Program and its expenditures: (a) what were the total annual expenditures under the program, for each fiscal year from 2016 through 2024, broken down by (i) basic health services, (ii) supplemental health services, (iii) prescription drugs, (iv) dental services; (b) how many individuals were enrolled in the program or received the program coverage, for each fiscal year from 2016 through 2024, broken down by (i) basic health services, (ii) supplemental health services, (iii) prescription drugs, (iv) dental services; (c) what was the total number of individuals covered under the program, for each fiscal year from 2016 through 2024, further broken down by (i) province or territory of residence, (ii) gender, (iii) age group (under 18, 18-64, and 65+), (iv) country of origin; (d) what were the total payments made to health care providers under the program, for each fiscal year from 2016 through 2024, broken down by (i) physicians, (ii) hospitals, (iii) pharmacies, (iv) dental providers, (v) province or territory; (e) what were the total administrative costs of the program, for each fiscal year from 2016 through 2024, broken down by (i) costs associated with claims processing, (ii) costs associated with oversight and program management, (iii) fees paid to members of the Canadian Association of Blue Cross Plans; and (f) what measures have been implemented since 2016 to ensure transparency and accountability in the allocation and expenditure of funds under the program, including any audits, reviews or evaluations conducted, and what were the findings of such audits or reviews?
In the House of Commons on September 15th, 2025. See this statement in context.